Quantitative Molecular Imaging of Viral Therapy for Pancreatic Cancer Using an Engineered Measles Virus Expressing the Sodium-Iodide Symporter Reporter Gene
- 1 January 2009
- journal article
- research article
- Published by American Roentgen Ray Society in American Journal of Roentgenology
- Vol. 192 (1) , 279-287
- https://doi.org/10.2214/ajr.08.1205
Abstract
OBJECTIVE. Our objectives were to, first, determine the oncolytic potential of an engineered measles virus expressing the sodium-iodide symporter gene (MV-NIS) for intratumoral (IT) therapy of pancreatic cancer and, second, evaluate NIS as a reporter gene for in vivo monitoring and quantitation of MV-NIS delivery, viral spread, and gene expression in this tumor model.MATERIALS AND METHODS. Cultured human pancreatic cancer cells were infected with MV-NIS. Light microscopy, cell viability, and iodide uptake assays were used to confirm viral infection and NIS gene expression and function in vitro. Human pancreatic tumor xenografts were established in mice and infected via IT MV-NIS injections. NIS-mediated IT iodide uptake was quantitated by 123I micro-SPECT/CT. IT MV-NIS infection was confirmed by immunohistochemistry of excised pancreatic xenografts. The oncolytic efficacy of MV-NIS was determined by measurement of tumor growth and mouse survival.RESULTS. Infection of human pancreatic cancer cell lines wit...Keywords
This publication has 33 references indexed in Scilit:
- Treatment Options for Hepatobiliary and Pancreatic CancerMayo Clinic Proceedings, 2007
- Engineered measles virus as a novel oncolytic viral therapy system for hepatocellular carcinomaHepatology, 2006
- Adenovirus-Mediated and Targeted Expression of the Sodium–Iodide Symporter PermitsIn VivoRadioiodide Imaging and Therapy of Pancreatic TumorsHuman Gene Therapy, 2006
- Dual Therapy of Ovarian Cancer Using Measles Viruses Expressing Carcinoembryonic Antigen and Sodium Iodide SymporterClinical Cancer Research, 2006
- Pharmacokinetics of oncolytic measles virotherapy: eventual equilibrium between virus and tumor in an ovarian cancer xenograft modelCancer Gene Therapy, 2006
- Mathematical modeling of cancer radiovirotherapyMathematical Biosciences, 2005
- In vivo Radioiodide Imaging and Treatment of Breast Cancer Xenografts after MUC1-Driven Expression of the Sodium Iodide SymporterClinical Cancer Research, 2005
- Genetically targeted radiotherapy for multiple myelomaBlood, 2003
- In vivo sodium iodide symporter gene therapy of prostate cancerGene Therapy, 2001
- Iodide Uptake and Experimental 131I Therapy in Transplanted Undifferentiated Thyroid Cancer Cells Expressing the Na+/I- Symporter GeneEndocrinology, 1997